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lo-  -lactamase groups VIM and IMP can render these 
bacteria carbapenem resistant. The   -lactamase genes 
 bla  IMP  and  bla  VIM  were first described in 1991 and 1999, 
respectively  [2, 3] . Since then they have been identified in 
several Asian and European countries and more recently 
in the Americas, including the USA. The mobile elements 
harbouring these resistance genes not only confer resis-
tance to the carbapenems but usually also to other   -lac-
tams, aminoglycosides and fluoroquinolones. The dis-
semination of these metallo-  -lactamases is an increas-
ing global threat to the effective treatment of  P. 
aeruginosa infections; however, our understanding of 
these resistance mechanisms has been restricted to the 
genotypic classification of the different genes and the 
phenotypic expression of their resistance profiles. The 
aim of this study was to understand the dynamics of the 
selection of strains harbouring the resistance genes  bla  VIM  
and  bla  IMP , and the ability of these carbapenemases to 
confer resistance to the carbapenems imipenem and me-
ropenem in  P. aeruginosa .
 Materials and Methods 
 Bacterial Isolates 
 P. aeruginosa strains, containing  bla  VIM-2  and  bla  IMP-1 , were 
kindly provided by Dr. N. Woodford. The susceptible  P. aerugi-
nosa strain ATCC 27853 was used as the susceptible comparator 
strain. The antimicrobial agents were obtained from their respec-
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 Abstract 
 Mixed populations of  Pseudomonas aeruginosa,  comprising 
a carbapenem-susceptible and a carbapenem-resistant 
strain, containing either the IMP or VIM   -lactamases, were 
exposed to imipenem. They developed resistance to both 
imipenem and meropenem. When the same mixed popula-
tions were exposed to meropenem, only the mixture con-
taining the VIM   -lactamases became resistant to both car-
bapenems.  Copyright © 2007 S. Karger AG, Basel 
 Introduction 
 Pseudomonas aeruginosa is capable of causing many 
types of infection and is a potent source of hospital-ac-
quired infection. In many cases the causative organism is 
resistant to a wide range of antimicrobial agents, which 
reduces the number of therapeutic options.  P. aeruginosa 
also has the ability to develop resistance simultaneously 
to more than 1 class of antibiotics, such as the fluoroqui-
nolones and carbapenems  [1] . The carbapenems imipe-
nem and meropenem have excellent activity against this 
pathogen; however, acquisition of the transferable metal-
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tive manufacturers and stored and prepared according to the 
manufacturer’s guidelines. The susceptibilities of imipenem, me-
ropenem and ertapenem to the 3 isolates were performed accord-
ing to the guidelines of the British Society for Antimicrobial Che-
motherapy  [4] .
 Competition Studies 
 The ability of a bacteria population to develop resistance is 
usually measured by the ability to mutate. This may not be an ac-
curate representation of the rise of resistance within a sensitive 
population. Instead, we have devised the following competition 
studies to establish the proliferation and dominance of the strains 
containing  bla  VIM-2  and  bla  IMP-1  over sensitive strains under an-
tibiotic challenge. These competition studies enable the analysis 
of a continuous mixed culture of bacteria and the differential se-
lection of resistant isolates over susceptible isolates and are de-
signed to provide a detailed picture of how metallo-  -lactamase-
producing, carbapenem-resistant isolates emerged from the pop-
ulation.
 Both the  bla  VIM-2 - and  bla  IMP-1 -containing isolates and the 
sensitive  P. aeruginosa isolate were grown overnight in iso-sensi-
test broth at 37  °  C in an orbital shaking incubator. Each resistant 
strain culture (0.1 ml) was mixed with 9.9 ml of the sensitive 
strain in separate sterile universal containers. Imipenem or me-
ropenem was added to the broth mixture at time 0 at a concentra-
Table 1. Minimum inhibitory concentrations of carbapenems for 
the 3 test strains
Imipenem Meropenem Ertapenem
VIM, mg/l 128 64 >128
IMP, mg/l 128 >128 >128
ATCC 27853, mg/l 1 0.25 4
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 Fig. 1.  Meropenem competition studies.  P. aeruginosa containing 
either the VIM or the IMP   -lactamase strains were mixed with 
the sensitive strain and then challenged with meropenem. The 
mixture was serially diluted at the time intervals shown and plat-
ed onto agar plates containing meropenem (MEM) or imipenem 
(IPM). 
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Fig. 2.  Imipenem competition studies.  P. aeruginosa containing 
either the VIM or IMP   -lactamase strains were mixed with the 
sensitive strain and then challenged with imipenem. The mix-
ture was serially diluted at the time intervals shown and plated 
onto agar plates containing meropenem (MEM) or imipenem 
(IPM). 
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tion of 1 mg/l. The broth was serially diluted and spread on plates 
with imipenem and meropenem at concentrations of 8 mg/l and 
on plates with no antibiotic at regular time intervals. The colonies 
were counted and the percentage resistance development calcu-
lated for each strain and antibiotic:
.
Results
 The minimum inhibitory concentrations of imipen-
em, meropenem and ertapenem for the 3 strains used in 
this study are shown in  table 1 . When meropenem was 
added to the broth containing the  bla  VIM-2 -resistant and 
sensitive strains, the percentage resistance to meropenem 
increased from approximately 3 to 100% within 30 h 
( fig. 1 ). The percentage resistance to imipenem increased 
to approximately 90% within 6 h; the proportion of the 
 bla  VIM-2 -resistant strain reduced after these peaks. This 
result was in stark contrast to the result obtained when 
meropenem was added to the broth containing the
 bla  IMP-1 -resistant and sensitive strains; in this case the 
percentage resistance to meropenem and imipenem re-
mained very low, the  bla  IMP-1 -resistant strain never rose 
higher than 1%. 
 When imipenem was added to the broth containing 
the  bla  VIM-2 -resistant and sensitive strains, the percent-
age of meropenem resistance caused by the VIM strain 
remained below 15% ( fig. 2 ), actually only representing a 
gradual rise from 2.2% in 48 h. On the other hand, the 
percentage resistance to imipenem increased to 37% after 
48 h. When the experiment was repeated with the IMP 
strain in the mixture, meropenem resistance remained at 
 ! 1% throughout the experiment, whereas imipenem re-
sistance increased to 22% after only 6 h.
 Exposure of the mixture of  bla  VIM-2 -resistant  and sen-
sitive  strains to meropenem allowed the  bla  VIM-2  strain to 
proliferate and dominate the culture, conferring resis-
tance to both imipenem and meropenem. Challenging 
the same mixture with imipenem resulted in a lower pro-
portion of resistance to meropenem and imipenem. Ex-
posure of the mixture containing the  bla  IMP-1  strain to 
meropenem resulted in almost no selection of meropen-
em or imipenem resistance, but exposure of the  bla  IMP-1  
strain mixture to imipenem resulted only in the develop-
ment of imipenem resistance.
Discussion
 This study has shown that challenge with imipenem 
promotes the selection of strains carrying either metallo-
  -lactamase, whereas meropenem only promotes the se-
lection of strains carrying the VIM metallo-  -lactamase 
and hinders the selection of the strain harbouring the 
IMP metallo-  -lactamase in vitro. It is interesting to note 
that the IMP metallo-  -lactamase was the first of this 
family of   -lactamases to emerge and spread worldwide 
and it is tempting to link this with the earlier release of 
imipenem. In countries where there has been a more fo-
cussed use of meropenem, strains carrying the VIM   -
lactamase have slowly emerged. It would be noteworthy 
to investigate the prescribing practices of the hospitals in 
which isolates containing the VIM and IMP   -lactamases 
have occurred and to compare this with the practices of 
hospitals which do not currently have a problem, to de-
termine whether exposure to meropenem prevented the 
emergence of  P .  aeruginosa containing the IMP   -lac-
tamase.
 Acknowledgement 
 This project was funded by an AstraZeneca educational 
grant. 
 References 
 1 Hideaki Muramatsu, Toshinobu Horii, Aki-
hiro Takeshita,  et al: Characterization of f lu-
oroquinolone and carbapenem susceptibili-
ties in clinical isolates of levofloxacin-resis -
tant  Pseudomonas aeruginosa.  Chemo therapy 
2005;  51:  70–75. 
 2 Lauretti L, Riccio ML, Mazzariol A, et al: 
Cloning and characterization of  bla  VIM , a 
new integron-borne metallo-  -lactamase 
gene from a  Pseudomonas aeruginosa  clini-
cal isolate. Antimicrob Agents Chemother 
1999;  43:  1584–1590. 
 3 Watanabe M, Iyobe S, Inoue M, et al: Trans-
ferable imipenem resistance in  Pseudomonas 
aeruginosa . Antimicrob Agents Chemother 
1991;  35:  147–151. 
 4 Andrews JM: Determination of minimum 
inhibitory concentrations. J Antimicrob 
Chemother 2001;  48(suppl 1):5–16. 
 
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
